Evidence map›Paper›PMID 32080231›Full record

ArticleScientific reports2020

Inhibition of Porphyromonas gulae and periodontal disease in dogs by a combination of clindamycin and interferon alpha.

Ryota Nomura, Hiroaki Inaba, Hidemi Yasuda, Mitsuyuki Shirai, Yukio Kato, Masaru Murakami, Naoki Iwashita, So Shirahata, Sho Yoshida, Saaya Matayoshi and 5 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Virulence · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in veterinary science · 2024
    Article
  11. Article
  12. Article
  13. Possible association ofFrontiers in veterinary science · 2023
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Ryota Nomura *Department of Pediatric Dentistry, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan. rnomura@dent.osaka-u.ac.jp.
Hiroaki Inaba *Department of Pediatric Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Hidemi Yasuda *Yasuda Veterinary Clinic, Meguro, Tokyo, Japan.
Mitsuyuki ShiraiDepartment of Pharmacology, School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa, Japan.
Yukio KatoDepartment of Veterinary Public Health II, School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa, Japan.
Masaru MurakamiDepartment of Molecular Biology, School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa, Japan.
Naoki IwashitaDepartment of Pharmacology, School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa, Japan.
So ShirahataPrimo Animal Hospital, Sagamihara, Kanagawa, Japan.
Sho YoshidaDepartment of Pediatric Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Saaya MatayoshiDepartment of Pediatric Dentistry, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
Junya YasudaYasuda Veterinary Clinic, Meguro, Tokyo, Japan.
Nobuaki AraiYasuda Veterinary Clinic, Meguro, Tokyo, Japan.
Fumitoshi AsaiDepartment of Pharmacology, School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa, Japan.
Michiyo Matsumoto-NakanoDepartment of Pediatric Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Kazuhiko NakanoDepartment of Pediatric Dentistry, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.ORCID http://orcid.org/0000-0002-2209-2685
Azabu University · JPOkayama University · JPThe University of Osaka · JPOsaka Gakuin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porphyromonas gulae is a major periodontal pathogen in dogs, which can be transmitted to their owners. A major virulence factor of P. gulae consists of a 41-kDa filamentous appendage (FimA) on the cell surface, which is classified into three genotypes: A, B, and C. Thus far, inhibition of periodontal disease in dogs remains difficult. The present study assessed the inhibitory effects of a combination of clindamycin and interferon alpha (IFN-α) formulation against P. gulae and periodontal disease. Growth of P. gulae was significantly inhibited by clindamycin; this inhibition had a greater effect on type C P. gulae than on type A and B isolates. In contrast, the IFN-α formulation inhibited the expression of IL-1β and COX-2 elicited by type A and B isolates, but not that elicited by type C isolates. Furthermore, periodontal recovery was promoted by the administration of both clindamycin and IFN-α formulation to dogs undergoing periodontal treatment; moreover, this combined treatment reduced the number of FimA genotypes in oral specimens from treated dogs. These results suggest that a combination of clindamycin and IFN-α formulation inhibit P. gulae virulence and thus may be effective for the prevention of periodontal disease induced by P. gulae.

Indexed as

AnimalsBacteroidaceae InfectionsCell LineClindamycinCytokinesDogsDrug DesignEpithelial CellsFemaleFimbriae ProteinsGenotypeGingivaHumansInterferon-alphaMalePeriodontal DiseasesClindamycinCytokinesFimbriae ProteinsfimbrillinInterferon-alphaVirulence Factors

Identifiers

PMID32080231
PMCPMC7033253
OpenAlexW3006837311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.